Company Filing History:
Years Active: 2024
Title: Matthias Riepl: Innovator in Pharmaceutical Chemistry
Introduction
Matthias Riepl is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new processes for drug production. His work is characterized by a focus on high yields and chemical purity.
Latest Patents
Riepl holds a patent for a process for the production of substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives. This invention relates specifically to a new method for producing 2-[2-(3-butoxyphenyl)-ethylamino]-N,N-dimethylacetamide in high yields with very high chemical purity. The patent showcases his innovative approach to pharmaceutical manufacturing.
Career Highlights
Throughout his career, Matthias Riepl has been associated with Newron Pharmaceuticals S.p.A., where he has played a crucial role in advancing pharmaceutical research and development. His expertise in chemical processes has contributed to the company's success in the industry.
Collaborations
Riepl has collaborated with notable colleagues, including Wolfgang Skranc and Michael Wolberg. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Matthias Riepl is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug production processes. His contributions continue to impact the field positively.